Interventional Pain Management in Colombia

Interventional pain management sits between two extremes that fail many people. On one side is systemic medication — anti-inflammatories, and in some countries opioids — which floods the whole body to treat a problem in one small area, with side effects that accumulate. On the other side is surgery, which is definitive but significant, and which many chronic pain patients either do not need or are not candidates for.

The interventional approach is different in kind: it delivers a targeted treatment precisely to the anatomical structure generating the pain, under image guidance, as an outpatient. A tiny volume of medication placed exactly where it matters can achieve what a much larger systemic dose cannot, without the systemic cost.

Two things make it work, and both are non-negotiable. The first is an accurate diagnosis: back pain can come from a disc, a facet joint, a sacroiliac joint, a nerve root, muscle, or a combination, and each calls for a different target. The second is image guidance. Fluoroscopy or ultrasound turns an approximate injection into a precise one, and in this field precision is the difference between a procedure that works and one that does nothing. Any clinic offering these injections without imaging is not practicing interventional pain medicine. Our chronic pain program covers the full range of options, including the conservative ones that should usually come first.

Facet joints are the small paired joints at the back of the spine that guide and limit movement. Like any joint they develop arthritis, and when they do the pain is typically localized to the back or neck, worse with extension and rotation, and often described as a deep ache rather than a shooting nerve pain.

What makes facet pain distinctive is that imaging cannot confirm it. Facet arthritis is visible on scans in a large share of people who have no pain at all, so the scan cannot tell you whether these joints are your pain source. The only way to establish it is a diagnostic block: anesthetic is placed either into the joint or, more commonly, alongside the medial branch nerves that supply it. If your pain drops substantially for the duration of the anesthetic, the joints are implicated. If it does not, they are not — and that negative result is genuinely valuable, because it stops you spending money on a treatment aimed at the wrong structure.

This is why blocks serve two purposes at once: they are diagnostic tests and they provide temporary relief. And it is why the sequence matters so much. A physician who proposes radiofrequency ablation without first confirming the diagnosis with blocks is skipping the step that determines whether the expensive procedure has any chance of working. In Colombia a block or facet injection commonly starts around $350 to $600 USD, against roughly $1,000 to $2,500 in the United States.

Not all interventional pain work is spinal. Peripheral joints — knees, hips, shoulders — are frequently treated with image-guided injections, and there are three broad categories worth distinguishing honestly.

Corticosteroid injections reduce inflammation and can give useful relief for weeks to a few months. They are inexpensive and well established, but repeated frequently into the same joint they carry concerns about cartilage, so they are used judiciously rather than on a schedule.

Viscosupplementation means injecting hyaluronic acid, a component of natural joint fluid, most commonly in knee osteoarthritis. Some preparations combine hyaluronic acid with a corticosteroid to pair immediate anti-inflammatory effect with a longer-acting component. The evidence here is genuinely mixed: some patients report meaningful improvement lasting months, while several guideline bodies consider the average benefit modest. We present it on those terms rather than as a certainty.

Platelet-rich plasma uses growth factors concentrated from your own blood, and in Colombia commonly ranges from $350 to $900 USD per session against $1,000 to $2,500 in the U.S. Our PRP for joint pain article covers the evidence in detail, and PRP vs stem cells explains where each fits. For all three, the same rule applies: image guidance matters, and an injection is an adjunct to strengthening and load management, not a substitute for it.

The reasonable candidate has pain that has persisted beyond a few months, has genuinely attempted conservative care — physiotherapy, activity modification, appropriate medication — and has a pain source that can be identified and targeted. That last condition does most of the work: interventional procedures treat a specific anatomical structure, so if nobody can say which structure is responsible, there is nothing to aim at.

Equally important is who should not proceed. Anyone with red flag symptoms — progressive weakness, foot drop, loss of bowel or bladder control, saddle anesthesia, unexplained weight loss with new back pain, or fever — needs urgent conventional evaluation, not an injection. Active infection, whether systemic or at the injection site, must be resolved first. Uncontrolled bleeding disorders or anticoagulation that cannot safely be paused, uncontrolled diabetes, and pregnancy are further contraindications. And anyone who has not completed a real trial of physiotherapy is usually better served by doing that first.

There is a subtler exclusion worth naming: a mismatch between expectation and reality. If you are hoping a procedure will make an arthritic spine young again, no interventional treatment delivers that. What they deliver is pain reduction that makes function possible — and the patients who benefit most are those who use that window to rebuild strength and activity rather than treating the injection as the finish line.